Report from CVS Health

CVS Health Corp. (NYSE:CVS) issued a report on Wednesday with fourth-quarter results that beat analysts' estimates. The earnings figure beat forecasts.

The company reported $1.98 earnings per share and revenues of $76.6 billion. However, according to FactSet, analysts had expected earnings of $1.83 per share on revenue of $75.66 billion.

CVS Health Corp's share price, up 7% this year, has performed better than the S&P 500 Index overall, falling 5% since the start of the year.

CVS Health said in December that it expects adjusted earnings of $8.10 to $8.30 per share in 2022.

Analysts expect average earnings of $8.27 per share.

Health sector

Last month, on the 19th, UnitedHealth reported fourth-quarter earnings of $4.48, profit of $73.74 billion, compared with earnings per share guidance of $4.3 for total revenues of $72.98 billion

Johnson and Johnson's earnings beat analysts' expectations in January 25 for the fourth quarter, with quarterly earnings per share of $2.13 on total earnings of $24.8 billion.

CVS Health is one of the largest providers of prescription drugs in the US. The company's founders are: CVS Pharmacy and CVS Caremark. The company is headquartered in Woonsocket, Rhode Island, US.